EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Association between peripheral activated naive and double negative 2 B‐cell subsets and clinical parameters in lupus nephritis patients

Kittikorn Wangriatisak, Charlotte de Vries, Ravi Kumar Sharma iD, Wenqi Huang, Caroline Grönwall, Prapaporn Pisitkun, Iva Gunnarsson, Vivianne Malmström, Patchanee Chootong, Francesca Faustini iD

Scandinavian Journal of Immunology · 2025

DOI: 10.1111/sji.13427 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scandinavian Journal of Immunology, 2025. Verfasst von Kittikorn Wangriatisak und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology and Applied Technology, Faculty of Medical Technology, Mahidol University, Nakhon Pathom, Thailand. Hauptthemen laut MEDLINE: Lupus Nephritis, B-Lymphocyte Subsets. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Region Stockholm (Stockholm läns landstinget), klinisk post-dok program (RS-2022-0704/FoUI-989648), Stiftelsen Stig och Gunborg Westman för forskning kring njursjukdomar, organtransplantation och organdonation, National Research Council of Thailand (NRCT): NRCT5-RGJ63012-121 (KW).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Altered composition of B‐cell compartments is a known feature in patients with systemic lupus erythematosus (SLE). However, deep characterisation of B‐cell subsets and their relation to clinical manifestations and disease activity in patients is limited. In this study, we analysed peripheral B‐cell subsets phenotype in SLE ( n = 35) and healthy controls (HCs, n = 15) by spectral flow cytometry. Disease activity was stratified as inactive (SLEDAI‐2 K score 0, n = 2), mild (SLEDAI‐2 K score 1–5, n = 12), moderate (SLEDAI‐2 K score 6–10, n = 6) or high (SLEDAI‐2 K > 10, n = 15). An elevated proportion of activated naive (aNAV), double negative 2 (DN2) and plasmablasts (PB) was observed in patients with high disease activity, compared to other groups of patients and HCs. An upregulation of BTLA was found on both aNAV and DN2 and shifted to lower levels with increasing disease activity. In lupus nephritis (LN) patients ( n = 21), aNAV B‐cells were especially expanded and positively correlated with DN2 ( r = 0.5, p = 0.019) and PB ( r = 0.43, p = 0.048). Also, correlation was observed between DN2 and PB ( r = 0.6, p = 0.003). Moreover, aNAV frequencies positively correlated with SLEDAI‐2 K score, and negatively with the complement fractions C3 and C4. Further, aNAV, DN2 and PB were more expanded in association with positive anti‐dsDNA antibodies, rather than other antibody specificities (anti‐Sm). These data suggest roles of extrafollicular B cells as key players in disease development of LN. Their association with presence of anti‐dsDNA antibodies may indicate their value as candidate biomarkers of kidney involvement in SLE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus NephritisB-Lymphocyte SubsetsHumansFemaleMaleAdultMiddle AgedAntibodies, AntinuclearFlow CytometryLymphocyte ActivationReceptors, ImmunologicYoung AdultLupus Erythematosus, SystemicSeverity of Illness Index

Stichwörter der Autor:innen

activated naïve; double negative 2disease activitylupus nephritis

Substanzen

Antibodies, AntinuclearBTLA protein, humanReceptors, Immunologic

Autor:innen und Institutionen

  • Department of Clinical Microbiology and Applied Technology, Faculty of Medical Technology, Mahidol University, Nakhon Pathom, Thailand.
  • Division of Rheumatology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Division of Allergy, Immunology and Rheumatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Medicine Unit Dermatology, Gastroenterology, Rheumatology; Unit of Rheumatology, Karolinska University Hospital Solna, Stockholm, Sweden.

ORCID-Profile: Ravi Kumar Sharma, Francesca Faustini

Förderung

  • Region Stockholm (Stockholm läns landstinget), klinisk post-dok program (RS-2022-0704/FoUI-989648)
  • Stiftelsen Stig och Gunborg Westman för forskning kring njursjukdomar, organtransplantation och organdonation
  • National Research Council of Thailand (NRCT): NRCT5-RGJ63012-121 (KW)
  • Stiftelsen Konung Gustaf V:s 80-årsfond
  • Reumatikerförbundet
  • Region Stockholm (Stockholm läns landistinget) ALF medel

Zitieren

APA

Wangriatisak, K., de Vries, C., Sharma, R. K., Huang, W., Grönwall, C., Pisitkun, P., Gunnarsson, I., Malmström, V., Chootong, P., & Faustini, F. (2025). Association between peripheral activated naive and double negative 2 B‐cell subsets and clinical parameters in lupus nephritis patients. Scandinavian Journal of Immunology. https://doi.org/10.1111/sji.13427

Vancouver

Wangriatisak K, de Vries C, Sharma RK, Huang W, Grönwall C, Pisitkun P, et al. Association between peripheral activated naive and double negative 2 B‐cell subsets and clinical parameters in lupus nephritis patients. Scandinavian Journal of Immunology. 2025. doi:10.1111/sji.13427

BibTeX
@article{Wangriatisak2025,
  author = {Wangriatisak, Kittikorn and de Vries, Charlotte and Sharma, Ravi Kumar and Huang, Wenqi and Grönwall, Caroline and Pisitkun, Prapaporn and Gunnarsson, Iva and Malmström, Vivianne and Chootong, Patchanee and Faustini, Francesca},
  title = {Association between peripheral activated naive and double negative 2 B‐cell subsets and clinical parameters in lupus nephritis patients},
  journal = {Scandinavian Journal of Immunology},
  year = {2025},
  doi = {10.1111/sji.13427}
}
Kostenlos starten →